Product Information
RITALIN LA 30 MG CAPSULE is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $12.3878 per EA under NDC 00078037105. Its NADAC has been published 384 times since Nov 28, 2013.
Strength
30 mg/1
Manufacturer
Novartis Pharmaceuticals CorporationNDC
00078037105
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
10/22/2025
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA021284On Market Since
6/5/2002
Pharmacological Classes
Price Statistics
The NADAC for RITALIN LA 30 MG CAPSULE has been published 384 times since Nov 28, 2013, and over the history we have for it it has risen 136.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.3878 per EA |
|---|---|
| All-time high | $12.4219 (Mar 12, 2025) |
| All-time low | $5.2303 (Nov 28, 2013) |
| 52-week high | $12.3962 |
| 52-week low | $12.3878 |
| Median price | $9.4443 |
| Average price | $9.3388 |
| Largest weekly change | +25.1% (Apr 17, 2024) |
| Weeks tracked | 384 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 85% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RITALIN LA 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for RITALIN LA 30 MG CAPSULE, manufactured by Novartis Pharmaceuticals Corporation, is $12.3878 per EA (NDC 00078037105), effective Jun 24, 2026.
How has the price of RITALIN LA 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for RITALIN LA 30 MG CAPSULE has risen 136.8%. It has been tracked across 384 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for RITALIN LA 30 MG CAPSULE?
Since Nov 28, 2013, the NADAC for RITALIN LA 30 MG CAPSULE has ranged from a low of $5.2303 (Nov 28, 2013) to a high of $12.4219 (Mar 12, 2025), with a median of $9.4443 per EA.
Are there cheaper alternatives to RITALIN LA 30 MG CAPSULE?
Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, METHYLPHENIDATE CD 30 MG CAP, is $1.8150 per EA — about 85% below RITALIN LA 30 MG CAPSULE.
Who manufactures RITALIN LA 30 MG CAPSULE?
RITALIN LA 30 MG CAPSULE (NDC 00078037105) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.
Related Drugs
Same classification